 The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore
The Phosphate Company Ltd Q2FY26 loss at Rs. 2.48 crore Emami Paper Mills Ltd Q2 FY2026 profit at Rs. 6.58 crores
Emami Paper Mills Ltd Q2 FY2026 profit at Rs. 6.58 crores Maruti Suzuki India Ltd Q2 FY2026 consolidated PAT slips QoQ to Rs. 3349 crores
Maruti Suzuki India Ltd Q2 FY2026 consolidated PAT slips QoQ to Rs. 3349 crores RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores
RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 
              Panacea Biotec Ltd had allotted 1,63,00,000 (One Crore Sixty Three Lac Only) 0.5%, Non-Convertible Cumulative Redeemable Preference Shares ('NCCRPS') of Rs.10 (Rupees Ten) each at par aggregating to Rs. 16.30 (Rupees Sixteen Crore Thirty lac Only) on private placement basis to the promotes of the Company in pursuance of Special Resolution passed by the shareholders in their Extra-Ordinary General Meeting held on January 06, 2015 at the Registered Office of the Company.
Further, the aforesaid shares are issued in physical form and the Company does not intend to list the aforesaid shares on Stock exchange(s).
Shares of PANACEA BIOTEC LTD. was last trading in BSE at Rs.146.65 as compared to the previous close of Rs. 149.35. The total number of shares traded during the day was 9385 in over 603 trades.
The stock hit an intraday high of Rs. 151.6 and intraday low of 146. The net turnover during the day was Rs. 1391502.